DexCom eased today but stayed on track to be the S&P 500's best October performer with a month-to-date gain of 50.6%. The rally comes as maker of glucose monitoring systems reported last week third-quarter results that beat expectations and got a boost from the Centers for Medicare and Medicaid Services' issuing a proposal that would expand the coverage of glucose monitoring devices.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.